MEDIA | The Australian | “CUREator funds 19 new therapeutics research projects”

The Australian’s Tim Dodd has published an article summarising the Medical Research Future Fund CUREator funding announcement.

Cyteph received a $1.5m grant last night, a significant boost for the Company’s efforts to positively contribute to the cancer therapeutics space.

An excerpt:

The key to the therapy is that Cyteph’s technology pre-trains the donated cells to kill glioblastoma multiforme. “They don’t have to retrain inside the body, they are pre-trained,” Professor Khanna says, and this speeds up the treatment.

It is also efficient, with a single blood donation from a healthy person providing enough T cells to treat 50 or more patients.

“This is a starting point. Our long term goal is to take it beyond brain cancer and treat other cancers,” Professor Khanna says.

Click here to read the full article.



300 Herston Road
Herston 4006 QLD Australia